Skip to main content

King Pharmaceuticals, Inc. Investors File Lawsuit Against Buyout

  • If you are a current investor in King Pharmaceuticals, Inc. (NYSE:KG) shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

An investor in King Pharmaceuticals, Inc. (NYSE:KG) filed a lawsuit in State Court against King Chairman and CEO, King directors and others alleging breaches of fiduciary duties arising out of their attempt to sell King Pharmaceuticals too cheaply via an unfair process to Pfizer Inc. According to the complaint the plaintiff alleges that King Pharmaceuticals Chairman and CEO and its B...



You must register (for free) or login to view the entire case.